Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
暂无分享,去创建一个
P. Calverley | C. Jenkins | S. Hurd | K. Rabe | C. van Weel | A. Anzueto | R. Rodríguez-Roisín | P. Barnes | Y. Fukuchi | J. Zieliński | S. Buist
[1] D. Postma,et al. Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease. , 1995, Thorax.
[2] A. Ionescu,et al. Attaining a correct diagnosis of COPD in general practice. , 2005, Respiratory medicine.
[3] S. Spencer,et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease , 2003, Thorax.
[4] L. Allegra,et al. Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial. , 1996, Respiration; international review of thoracic diseases.
[5] J. Higgins,et al. A systematic review of the use of opioids in the management of dyspnoea , 2002, Thorax.
[6] C. Westermann,et al. Bullectomy for giant bullae in emphysema. , 1986, The Journal of thoracic and cardiovascular surgery.
[7] D. Tashkin,et al. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. , 2003, Chest.
[8] L Goldman,et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.
[9] T. Omland,et al. Underdiagnosis of myocardial infarction in COPD - Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation. , 2008, Respiratory medicine.
[10] M. S. Singh,et al. Development of a shuttle walking test of disability in patients with chronic airways obstruction. , 1992, Thorax.
[11] R. Stockley,et al. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. , 2000, Chest.
[12] B. Dautzenberg,et al. European Respiratory Society Guidelines on the use of nebulizers. , 2001, The European respiratory journal.
[13] S. Weingarten,et al. Reducing length of stay for patients hospitalized with exacerbation of COPD by using a practice guideline. , 1997, Chest.
[14] M. Cazzola,et al. Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study. , 1995, Respiratory medicine.
[15] R. Novick,et al. The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report--1998. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[16] Sally J. Singh,et al. A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease , 2001, Thorax.
[17] Margareta Emtner,et al. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. , 2003, American journal of respiratory and critical care medicine.
[18] P. Lange,et al. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial , 1999, The Lancet.
[19] F. Martinez,et al. Supported arm exercise vs unsupported arm exercise in the rehabilitation of patients with severe chronic airflow obstruction. , 1993, Chest.
[20] N. Hanania,et al. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD. , 2003, Chest.
[21] R. Casaburi,et al. Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. , 2002, Chest.
[22] K. Rabe,et al. Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD. , 2008, Chest.
[23] S. Spencer,et al. Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study , 2003, Thorax.
[24] L. Corbetta,et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[25] D. Jarvis,et al. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes , 2008, Thorax.
[26] N. Anthonisen,et al. Airways obstruction and the risk for lung cancer. , 1987, Annals of internal medicine.
[27] P. Calverley,et al. Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial , 2005, Thorax.
[28] L. Joossens,et al. TOBACCO PRODUCT REGULATION , 2006 .
[29] S. M. Lee,et al. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. , 2001, The European respiratory journal.
[30] E. Wouters,et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[31] J. Curtis,et al. Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction. , 2003, Chest.
[32] P. Tønnesen,et al. Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. , 2006, Chest.
[33] B. Celli,et al. Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey. , 2005, The American journal of medicine.
[34] J. Ruiz,et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. , 1995, American journal of respiratory and critical care medicine.
[35] D. Postma,et al. The European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): recruitment methods and strategies. , 1998, Respiratory medicine.
[36] U. Ackermann-Liebrich,et al. Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. , 1994, American journal of respiratory and critical care medicine.
[37] K. Chapman,et al. Physician perceptions and management of COPD. , 1993, Chest.
[38] A. Hardman,et al. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. , 1999, Thorax.
[39] M. Polkey,et al. Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD , 2004, Thorax.
[40] J. Barberà,et al. Gas exchange response to short-acting beta2-agonists in chronic obstructive pulmonary disease severe exacerbations. , 2007, American journal of respiratory and critical care medicine.
[41] B. Celli. Current thoughts regarding treatment of chronic obstructive pulmonary disease. , 1996, The Medical clinics of North America.
[42] E. Prescott,et al. Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study , 2003, European Respiratory Journal.
[43] A. Musk,et al. Upper-limb and lower-limb exercise training in patients with chronic airflow obstruction. , 1991, Chest.
[44] H. Chrystyn,et al. Dose response relation to oral theophylline in severe chronic obstructive airways disease. , 1988, BMJ.
[45] S. Rennard,et al. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[46] J. Finnerty,et al. The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: a randomized controlled trial. , 2001, Chest.
[47] J. V. van Noord,et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium , 2002, European Respiratory Journal.
[48] A. Buist,et al. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: An 85-day multicenter trial , 1994 .
[49] D. Hosmer,et al. Increasing the efficacy of physician-delivered smoking interventions , 2007, Journal of General Internal Medicine.
[50] R. Sharrar,et al. Passive smoking in obstructive respiratory disease in an industrialized urban population. , 1994, Environmental research.
[51] Y. Scherer,et al. Can a Pulmonary Health Teaching Program Alter Patients’ Ability to Cope with COPD? , 1991, Rehabilitation nursing : the official journal of the Association of Rehabilitation Nurses.
[52] Qing Lan,et al. Improvement in household stoves and risk of chronic obstructive pulmonary disease in Xuanwei, China: retrospective cohort study , 2005, BMJ : British Medical Journal.
[53] U Ackermann-Liebrich,et al. Lung function and long term exposure to air pollutants in Switzerland. Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) Team. , 1997, American journal of respiratory and critical care medicine.
[54] Peter C Gøtzsche,et al. Alpha1-antitrypsin deficiency. , 2009, The New England journal of medicine.
[55] F. Maltais,et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. , 2002, American journal of respiratory and critical care medicine.
[56] T. Petty. Supportive therapy in COPD. , 1998, Chest.
[57] D. Postma,et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. , 1999, The New England journal of medicine.
[58] Henry Chrystyn,et al. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help? , 2007, Respiratory medicine.
[59] N. Zhong,et al. Positive benefits of theophylline in a randomized, double‐blind, parallel‐group, placebo‐controlled study of low‐dose, slow‐release theophylline in the treatment of COPD for 1 year , 2006, Respirology.
[60] B. Grant,et al. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. , 2000, Chest.
[61] F. Ram. Use of theophylline in chronic obstructive pulmonary disease: examining the evidence , 2006, Current opinion in pulmonary medicine.
[62] P. Young,et al. Improvements in outcomes for chronic obstructive pulmonary disease (COPD) attributable to a hospital-based respiratory rehabilitation programme. , 1999, Australian and New Zealand journal of medicine.
[63] P. Weiner,et al. Inspiratory muscle training in pulmonary rehabilitation program in COPD patients. , 2007, Respiratory medicine.
[64] C F Donner,et al. Physiologic determinants of ventilator dependence in long-term mechanically ventilated patients. , 2000, American journal of respiratory and critical care medicine.
[65] Aker,et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.
[66] K. R. Chapman,et al. Epidemiology and costs of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.
[67] E. Wouters,et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. , 1993, The American review of respiratory disease.
[68] Niels H Chavannes,et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. , 2009, American journal of respiratory and critical care medicine.
[69] R. Barker,et al. Residual lung damage after completion of treatment for multidrug-resistant tuberculosis. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[70] P. Honeyman,et al. Effect of a walking aid on disability, oxygenation, and breathlessness in patients with chronic airflow limitation. , 1996, Journal of cardiopulmonary rehabilitation.
[71] Martyn Barnes,et al. Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places. , 2006, JAMA.
[72] C. Roberts,et al. UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation , 2006, Thorax.
[73] A. Schols,et al. Systemic effects in COPD. , 2002, Chest.
[74] N. Zhong,et al. Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study , 2008, The Lancet.
[75] P. Calverley,et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. , 2008, American journal of respiratory and critical care medicine.
[76] A. Torres,et al. Guidelines for the management of adult lower respiratory tract infections , 2005, European Respiratory Journal.
[77] N. Anthonisen,et al. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. , 1989, The American review of respiratory disease.
[78] Thierry Troosters,et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. , 2006, American journal of respiratory and critical care medicine.
[79] N. Rigotti,et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. , 2006, JAMA.
[80] T. Seemungal,et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[81] I. Vogiatzis,et al. Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD , 2004, European Respiratory Journal.
[82] C. Husten,et al. How to help your patients stop smoking. , 1978, American family physician.
[83] D. Lawlor,et al. Association of birth weight with adult lung function: findings from the British Women’s Heart and Health Study and a meta-analysis , 2005, Thorax.
[84] M. Fiore,et al. The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. , 1994, JAMA.
[85] C. Torp‐Pedersen,et al. Chronic obstructive pulmonary disease in patients admitted with heart failure , 2008, Journal of internal medicine.
[86] P. Poole,et al. The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[87] S. Tonstad,et al. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. , 2006, JAMA.
[88] P. Burgel,et al. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium , 2004, Thorax.
[89] P. Calverley,et al. Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease , 2004, Thorax.
[90] L. Trupin,et al. The occupational burden of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[91] J. V. van Noord,et al. One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease , 2004, European Respiratory Journal.
[92] D. Gruson,et al. Noninvasive pressure support ventilation in COPD patients with postextubation hypercapnic respiratory insufficiency. , 1998, The European respiratory journal.
[93] Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. , 2004, Thorax.
[94] R. Breiman,et al. Prevention of pneumococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1997 .
[95] K. Shianna,et al. A Genome-Wide Association Study in Chronic Obstructive Pulmonary Disease (COPD): Identification of Two Major Susceptibility Loci , 2009, PLoS genetics.
[96] B. Make,et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD , 2004, European Respiratory Journal.
[97] L. Cinotti,et al. Changes in the distribution of ventilation and perfusion associated with separation from mechanical ventilation in patients with obstructive pulmonary disease. , 1991, Anesthesiology.
[98] J. L. Schwartz. Review and evaluation of smoking cessation methods : the United States and Canada, 1978-1985 , 1987 .
[99] J. Fagon,et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. , 1990, The American review of respiratory disease.
[100] T. Murphy,et al. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.
[101] S. Davies,et al. Inhaled bronchodilators increase maximum oxygen consumption in chronic left ventricular failure. , 1993, European heart journal.
[102] P. Calverley. Symptomatic Bronchodilator Treatment , 1995 .
[103] J. Wedzicha,et al. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis , 2003, BMJ : British Medical Journal.
[104] J. Hogg,et al. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease , 2004, The Lancet.
[105] Omar Masera,et al. Improved biomass stove intervention in rural Mexico: impact on the respiratory health of women. , 2009, American journal of respiratory and critical care medicine.
[106] Cesar G Victora,et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study , 2005, The Lancet.
[107] E. Vittinghoff,et al. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. , 1995, JAMA.
[108] American College of Sports Medicine position stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness in healthy adults. , 1990, Medicine and science in sports and exercise.
[109] W. MacNee,et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.
[110] Ki Moon Bang,et al. Airflow obstruction attributable to work in industry and occupation among U.S. race/ethnic groups: a study of NHANES III data. , 2004, American journal of industrial medicine.
[111] E. Weitzenblum,et al. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[112] D. Wood,et al. Economic aspects of lung volume reduction surgery. , 1996, Chest.
[113] S. Lareau,et al. Pulmonary rehabilitation , 2001, Breathe.
[114] Michael C. Fiore,et al. A Clinical Practice Guideline for Treating Tobacco Use and Dependence A US Public Health Service Report , 2000 .
[115] N. Crepaz,et al. Higher incidence of clear cell adenocarcinoma of the cervix and vagina among women born between 1947 and 1971 in the United States , 2011, Cancer Causes & Control.
[116] C. Bucknall,et al. Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial , 2000, Thorax.
[117] T. Pechacek,et al. Physician-initiated smoking cessation program: the National Cancer Institute trials. , 1990, Progress in clinical and biological research.
[118] John E Connett,et al. Smoking and lung function of Lung Health Study participants after 11 years. , 2002, American journal of respiratory and critical care medicine.
[119] M J Tobin,et al. How is mechanical ventilation employed in the intensive care unit? An international utilization review. , 2000, American journal of respiratory and critical care medicine.
[120] J. Britton,et al. High-dose inhaled albuterol in severe chronic airflow limitation. , 1988, The American review of respiratory disease.
[121] J. Moxham. Aminophylline and the respiratory muscles: an alternative view. , 1988, Clinics in chest medicine.
[122] W. Bailey,et al. Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.
[123] B. Yawn,et al. Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.
[124] P. Jones,et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.
[125] B. Celli,et al. Long-term oxygen therapy. , 1995, The New England journal of medicine.
[126] Majid Ezzati,et al. Biomass fuels and respiratory diseases: a review of the evidence. , 2008, Proceedings of the American Thoracic Society.
[127] D. Sin,et al. Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis. , 2008, Chest.
[128] H. Fessler,et al. Lung volume reduction surgery and airflow limitation. , 1998, American journal of respiratory and critical care medicine.
[129] R. Zuwallack,et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.
[130] Calverley Pm. Neuropsychological deficits in chronic obstructive pulmonary disease. , 1996 .
[131] J. Gravil,et al. Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service , 1998, The Lancet.
[132] C. Jenkins,et al. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study , 2009, Respiratory research.
[133] M. Cosio,et al. Inflammation of the airways and lung parenchyma in COPD: role of T cells. , 2002, Chest.
[134] E. Bateman,et al. Effect of educational outreach to nurses on tuberculosis case detection and primary care of respiratory illness: pragmatic cluster randomised controlled trial , 2005, BMJ : British Medical Journal.
[135] N. Eiser,et al. Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome. , 1991, The European respiratory journal.
[136] K. Chon,et al. Ventilatory load characteristics during ventilatory muscle training. , 1994, American journal of respiratory and critical care medicine.
[137] F. D. de Serres,et al. Estimated numbers and prevalence of PI*S and PI*Z alleles of α1-antitrypsin deficiency in European countries , 2006, European Respiratory Journal.
[138] R. Casaburi,et al. Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients , 2008, International journal of chronic obstructive pulmonary disease.
[139] R. Berger,et al. Effect of inhaled metaproterenol on exercise performance in patients with stable "fixed" airway obstruction. , 1988, The American review of respiratory disease.
[140] F. Gallefoss. The effects of patient education in COPD in a 1-year follow-up randomised, controlled trial. , 2004, Patient education and counseling.
[141] M. Elliott,et al. Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome , 2001, Thorax.
[142] S. Spiro,et al. The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease. , 1988, The American review of respiratory disease.
[143] M. Stewart. Effective physician-patient communication and health outcomes: a review. , 1995, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[144] C. Mathers,et al. Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.
[145] Leo Smith,et al. American Association of Cardiovascular and Pulmonary Rehabilitation , 1986 .
[146] D. Postma,et al. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. , 2003, Thorax.
[147] K. Nishimura,et al. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone. , 1995, Chest.
[148] F. Maltais,et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[149] J. Heffner,et al. Outcomes of advance directive education of pulmonary rehabilitation patients. , 1997, American journal of respiratory and critical care medicine.
[150] N. Gross,et al. Inhalation by Nebulization of Albuterol-Ipratropium Combination (Dey Combination) Is Superior to Either Agent Alone in the Treatment of Chronic Obstructive Pulmonary Disease , 1998, Respiration.
[151] A. Laupacis,et al. Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. , 1999, Chest.
[152] N. Hanna,et al. Respiratory Symptoms, Pulmonary Function, and Markers of Inflammation Among Bar Workers Before and After a Legislative Ban on Smoking in Public Places , 2008 .
[153] P. Sagnier,et al. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. , 2004, Chest.
[154] G. Gibson,et al. Relation between FEV1 and peak expiratory flow in patients with chronic airflow obstruction. , 1988, Thorax.
[155] C. Ulrik. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study. , 1995, Thorax.
[156] N. Payne,et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial , 2000, The Lancet.
[157] N. Anthonisen,et al. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. , 2001, American journal of respiratory and critical care medicine.
[158] J. Cooper,et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. , 1995, The Journal of thoracic and cardiovascular surgery.
[159] N. Hill,et al. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. , 1995, American journal of respiratory and critical care medicine.
[160] J. Szidon,et al. Lung volume reduction surgery: an analysis of hospital costs. , 1998, Chest.
[161] L. Davies,et al. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial , 1999, The Lancet.
[162] R. Stockley,et al. Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis , 2003, Thorax.
[163] H. Date,et al. [Lung transplantation]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.
[164] Steven Piantadosi,et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.
[165] M. Fiore,et al. The Effectiveness of the Nicotine Patch for Smoking Cessation , 1994 .
[166] R. Casaburi,et al. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. , 2005, Chest.
[167] J. Concato,et al. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. , 2007, Archives of internal medicine.
[168] P. Calverley,et al. Cigarette smoking and secondary polycythemia in hypoxic cor pulmonale. , 1982, The American review of respiratory disease.
[169] D. Mannino,et al. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. , 2009, American journal of respiratory and critical care medicine.
[170] G. Guyatt,et al. Randomised controlled trial of respiratory rehabilitation , 1994, The Lancet.
[171] F. Martinez,et al. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials , 2009, The Lancet.
[172] B. Grant,et al. Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.
[173] R. Wood‐Baker,et al. Written action plans in chronic obstructive pulmonary disease increase appropriate treatment for acute exacerbations , 2006, Respirology.
[174] N. Chavannes,et al. Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD) , 2003, Thorax.
[175] G. Boman,et al. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. , 1983, European journal of respiratory diseases.
[176] Carolyn E Behrendt,et al. Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. , 2005, Chest.
[177] D. Mannino,et al. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. , 2003, The American journal of medicine.
[178] J. M. FitzGerald,et al. Bronchodilator delivery in acute airflow obstruction. A meta-analysis. , 1997, Archives of internal medicine.
[179] Kenneth P Moritsugu,et al. The 2006 Report of the Surgeon General: the health consequences of involuntary exposure to tobacco smoke. , 2007, American journal of preventive medicine.
[180] A. Giobbie-Hurder,et al. Effectiveness of team-managed home-based primary care: a randomized multicenter trial. , 2000, JAMA.
[181] S. Borg,et al. Costs of COPD in Sweden according to disease severity. , 2002, Chest.
[182] A I Mushlin,et al. The necessary length of hospital stay for chronic pulmonary disease. , 1991, JAMA.
[183] T. Ng,et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. , 2007, Archives of internal medicine.
[184] J. Yates,et al. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[185] M. Greenstone,et al. Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease. , 2002, The Cochrane database of systematic reviews.
[186] T. Evans. International Consensus Conferences in Intensive Care Medicine: Non-invasive positive pressure ventilation in acute respiratory failure , 2001, Intensive Care Medicine.
[187] Y. Lacasse,et al. Randomised trial of ambulatory oxygen in oxygen-dependent COPD , 2005, European Respiratory Journal.
[188] D. Jarvis,et al. Early life origins of chronic obstructive pulmonary disease , 2009, Thorax.
[189] C. van Weel,et al. Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program. , 1998, American journal of respiratory and critical care medicine.
[190] S. P. Gupta,et al. Physical rehabilitation for the chronic bronchitic: results of a controlled trial of exercises in the home. , 1977, Thorax.
[191] P. J. Barnes,et al. Systemic manifestations and comorbidities of COPD , 2009, European Respiratory Journal.
[192] Cotes Je,et al. LONG TERM DOMICILIARY OXYGEN THERAPY IN CHRONIC HYPOXIC COR PULMONALE COMPLICATING CHRONIC BRONCHITIS AND EMPHYSEMA Report of the Medical Research Council Working Party , 1981, The Lancet.
[193] T. Krone,et al. Economic benefits of teaching patients with chronic obstructive pulmonary disease about their illness , 1992, The Lancet.
[194] C. van Weel,et al. Prevalence of asthma and COPD in general practice in 1992: has it changed since 1977? , 1996, The British journal of general practice : the journal of the Royal College of General Practitioners.
[195] Yoon K Loke,et al. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. , 2009, Archives of internal medicine.
[196] T. Wilt,et al. Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). , 2005, Evidence report/technology assessment.
[197] M. Nichter. Introducing tobacco cessation in developing countries: an overview of Project Quit Tobacco International , 2006, Tobacco Control.
[198] T. Feenstra,et al. COPD: can prevention be improved? Proposal for an integrated intervention strategy. , 2004, Preventive medicine.
[199] N. Ambrosino,et al. Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. , 1999, The European respiratory journal.
[200] W. Stalman,et al. Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands. , 1998, Journal of epidemiology and community health.
[201] J. Roca,et al. Ventilation-perfusion mismatching in chronic obstructive pulmonary disease during ventilator weaning. , 1989, The American review of respiratory disease.
[202] A. Fishman. Pulmonary rehabilitation research. , 1994, American journal of respiratory and critical care medicine.
[203] J. Maurer. Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator: A Randomized Trial , 2007 .
[204] W. MacNee,et al. Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease. , 2000, Thorax.
[205] T. Meyer,et al. Noninvasive Positive Pressure Ventilation To Treat Respiratory Failure , 1994, Annals of Internal Medicine.
[206] Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. , 1997, Bulletin of the World Health Organization.
[207] Maria Aliani,et al. Prescription bias and factors associated with improper use of inhalers. , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[208] Richard Casaburi,et al. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. , 2007, Chest.
[209] M. Decramer,et al. Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma. , 1992, The American review of respiratory disease.
[210] D. Postma,et al. Chronic obstructive pulmonary disease. , 2002, Clinical evidence.
[211] A Rossi,et al. Respiratory mechanics in mechanically ventilated patients with respiratory failure. , 1985, Journal of applied physiology.
[212] B. Celli,et al. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. , 2006, Chest.
[213] D. O’Donnell,et al. The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. , 1995, American journal of respiratory and critical care medicine.
[214] J. Alonso,et al. Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients , 2003, European Respiratory Journal.
[215] W. Dejsomritrutai,et al. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. , 2004, Chest.
[216] T. Seemungal,et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.
[217] C. van Weel,et al. Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis. , 1991, Thorax.
[218] Tammy O. Tengs,et al. Five-hundred life-saving interventions and their cost-effectiveness. , 1995, Risk analysis : an official publication of the Society for Risk Analysis.
[219] M. Decramer,et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.
[220] E. Ernst,et al. Herbal medicines for the treatment of COPD: a systematic review , 2006, European Respiratory Journal.
[221] J Vestbo,et al. A 15-year follow-up study of ventilatory function in adults with asthma. , 1998, The New England journal of medicine.
[222] F. Martinez,et al. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. , 1997, American journal of respiratory and critical care medicine.
[223] Alyn H. Morice,et al. Patients' and carers' preferences in two models of care for acute exacerbations of COPD: results of a randomised controlled trial , 2002, Thorax.
[224] A Rossi,et al. Measurement of static compliance of the total respiratory system in patients with acute respiratory failure during mechanical ventilation. The effect of intrinsic positive end-expiratory pressure. , 1985, The American review of respiratory disease.
[225] R. Rodríguez-Roisín,et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. , 1998, American journal of respiratory and critical care medicine.
[226] W. Bailey,et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. , 1995, JAMA.
[227] Roger L. Brown,et al. Effectiveness of implementing the agency for healthcare research and quality smoking cessation clinical practice guideline: a randomized, controlled trial. , 2004, Journal of the National Cancer Institute.
[228] J. Vestbo,et al. Potential misclassification of causes of death from COPD , 2006, European Respiratory Journal.
[229] M. Miravitlles,et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. , 1999, Chest.
[230] tefan,et al. LONG-TERM TREATMENT WITH INHALED BUDESONIDE IN PERSONS WITH MILD CHRONIC OBSTRUCTIVE PULMONARY DISEASE WHO CONTINUE SMOKING , 2000 .
[231] J. Hankinson,et al. Standardisation of spirometry , 2005, European Respiratory Journal.
[232] D. Postma,et al. Quality of Life in Patients With Chronic Obstructive Pulmonary Disease Improves After Rehabilitation at Home , 1995 .
[233] C. Kim,et al. Comparative measurement of lung deposition of inhaled fine particles in normal subjects and patients with obstructive airway disease. , 1997, American journal of respiratory and critical care medicine.
[234] D. Flenley,et al. RESPIRATORY FAILURE REVISITED: ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS BETWEEN 1961-68 AND 1970-76 , 1980, The Lancet.
[235] C. Vogelmeier,et al. Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group, multicentre study , 2009, Respiratory research.
[236] P. Jones,et al. Health status measurement in chronic obstructive pulmonary disease , 2001, Thorax.
[237] Shengming Liu,et al. Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China , 2007, Thorax.
[238] Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis. , 1965, Lancet.
[239] F. Martinez,et al. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials , 2009, The Lancet.
[240] M. Hetzel,et al. Value of pulse oximetry in screening for long-term oxygen therapy requirement. , 1993, The European respiratory journal.
[241] E. Leslie Chusid,et al. PULMONARY FUNCTION TESTING GUIDELINES AND CONTROVERSIES , 1984 .
[242] M. Wysocki,et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. , 1995, The New England journal of medicine.
[243] R. Zuwallack,et al. Salmeterol plus theophylline combination therapy in the treatment of COPD. , 2001, Chest.
[244] A. Morice,et al. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) , 1997, The European respiratory journal.
[245] Ciro Casanova,et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[246] J. Deslauriers,et al. Indications for surgery and patient work-up for bullectomy. , 1995, Chest surgery clinics of North America.
[247] M. Tsukino,et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. , 2003, American journal of respiratory and critical care medicine.
[248] K. Godfrey,et al. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. , 1991, BMJ.
[249] J. Britton,et al. Helping people to stop smoking: the new smoking cessation guidelines , 1999, Thorax.
[250] K P Offord,et al. Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. , 1986, Annals of internal medicine.
[251] Fernando Holguin,et al. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. , 2005, Chest.
[252] I. Vogiatzis,et al. Interval training as an alternative modality to continuous exercise in patients with COPD , 2002, European Respiratory Journal.
[253] Kathleen Kreiss,et al. American Thoracic Society Statement: Occupational contribution to the burden of airway disease. , 2003, American journal of respiratory and critical care medicine.
[254] P. Enright,et al. Long-term particulate and other air pollutants and lung function in nonsmokers. , 1998, American journal of respiratory and critical care medicine.
[255] N. Anthonisen,et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.
[256] T. Petty. The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis. , 1990, Chest.
[257] J. Stradling,et al. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. , 1987, The American journal of medicine.
[258] D. Mannino,et al. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort , 2008, Thorax.
[259] G. Valdivia,et al. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America , 2007, European Respiratory Journal.
[260] K. Norris,et al. The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study. , 2001, The New Zealand medical journal.
[261] T. Petty,et al. Further recommendations for prescribing, reimbursement, technology development, and research in long-term oxygen therapy. Summary of the Fourth Oxygen Consensus Conference, Washington, D.C., October 15-16, 1993. , 1994, American journal of respiratory and critical care medicine.
[262] J. Theodore,et al. Lung transplantation comes of age. , 1990, The New England journal of medicine.
[263] P. Jones. Health Status and the Spiral of Decline , 2009, COPD.
[264] B. Celli,et al. The 6-min walking distance: long-term follow up in patients with COPD , 2007, European Respiratory Journal.
[265] Shun-zhang Yu,et al. Priority among air pollution factors for preventing chronic obstructive pulmonary disease in Shanghai. , 1992, The Science of the total environment.
[266] G. Valdivia,et al. Diagnostic labeling of COPD in five Latin American cities. , 2007, Chest.
[267] M. Wakefield,et al. “Sick of Smoking”: evaluation of a targeted minimal smoking cessation intervention in general practice , 1990, The Medical journal of Australia.
[268] B. Rowe,et al. Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials , 2003, BMJ : British Medical Journal.
[269] A. Adelman. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. , 1999, The Journal of family practice.
[270] J. Curtis,et al. Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease , 2006, Expert review of anti-infective therapy.
[271] T. Seemungal,et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.
[272] J. B. Rasmussen,et al. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis. , 1988, The European respiratory journal.
[273] J. Moxham,et al. Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. , 1987, Chest.
[274] N Künzli,et al. Public-health impact of outdoor and traffic-related air pollution: a European assessment , 2000, The Lancet.
[275] N. Adair,et al. Exercise rehabilitation and chronic obstructive pulmonary disease stage. , 1999, American journal of respiratory and critical care medicine.
[276] Mark E Kunik,et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. , 2005, Chest.
[277] R. Novick,et al. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease , 1998, The Lancet.
[278] H. Gong. Air travel and oxygen therapy in cardiopulmonary patients. , 1992, Chest.
[279] Ware J.E.Jr.,et al. THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .
[280] D. Hess,et al. Noninvasive positive pressure ventilation for acute respiratory failure. , 1999, International anesthesiology clinics.
[281] P. Paré,et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[282] B. Celli. Pulmonary rehabilitation in patients with COPD. , 1995, American journal of respiratory and critical care medicine.
[283] L. Boulet,et al. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. , 1998, Chest.
[284] M. Decramer,et al. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. , 1994, American journal of respiratory and critical care medicine.
[285] J. Vestbo,et al. Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. , 1999, The European respiratory journal.
[286] J. Erikssen,et al. Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males , 2005, European Respiratory Journal.
[287] P. Young,et al. Shortburst oxygen immediately before and after exercise is ineffective in nonhypoxic COPD patients , 2003, European Respiratory Journal.
[288] G. Criner,et al. Effect of lung volume reduction surgery on diaphragm strength. , 1998, American journal of respiratory and critical care medicine.
[289] J. van der Palen,et al. Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[290] N. Pride,et al. Recent trends in physician diagnosed COPD in women and men in the UK , 2000, Thorax.
[291] F. Maltais,et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. , 2003, Archives of internal medicine.
[292] B. Grant,et al. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. , 2005, American journal of respiratory and critical care medicine.
[293] J Zieliński,et al. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. , 1998, Chest.
[294] J. Garcia-Aymerich,et al. Wood smoke exposure and risk of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.
[295] A. Connors,et al. Theophylline concentrations in patients with acute exacerbation of COPD. , 1990, The American journal of emergency medicine.
[296] B. Celli,et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.
[297] R. Casaburi. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. , 1999, Medicine and science in sports and exercise.
[298] B. Celli,et al. The 6‐min walk distance: change over time and value as a predictor of survival in severe COPD , 2004, European Respiratory Journal.
[299] W. Kaufman. HOW TO HELP PATIENTS STOP SMOKING , 1954 .
[300] C. D. Mathers,et al. Chronic obstructive pulmonary disease: current burden and future projections , 2006, European Respiratory Journal.
[301] F. Abroug,et al. Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial , 2001, The Lancet.
[302] S. Ward,et al. Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease , 2005, Thorax.
[303] C. Sanguinetti,et al. Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation. , 1998, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[304] B. Celli,et al. Overall management of stable chronic obstructive pulmonary disease , 2006 .
[305] J. Connett,et al. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. , 1996, American journal of respiratory and critical care medicine.
[306] S. Spencer,et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.
[307] T. Lasserson,et al. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. , 2006, The Cochrane database of systematic reviews.
[308] J. Barberà,et al. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease , 1996, The Lancet.
[309] Ulrike Held,et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index , 2009, The Lancet.
[310] E. Bateman,et al. Guideline for the management of chronic obstructive pulmonary disease (COPD): 2004 revision. , 2004, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[311] M. Belman,et al. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[312] R. Klayton. RESPIRATORY INFECTIONS: A SCIENTIFIC BASIS FOR MANAGEMENT , 1995 .
[313] Ose,et al. A COMPARISON OF FOUR METHODS OF WEANING PATIENTS FROM MECHANICAL VENTILATION , 1997 .
[314] T. Witek,et al. Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. , 1999, Life sciences.
[315] E. Daviskas,et al. Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease. , 1989, Thorax.
[316] P. Buckley,et al. The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive pulmonary disease patients. , 1990, The American review of respiratory disease.
[317] J. Garrett,et al. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. , 1999, Chest.
[318] Toru Oga,et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. , 2002, Chest.
[319] M. Miravitlles,et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. , 2000, Chest.
[320] D. Tashkin,et al. Formoterol and Tiotropium Compared With Tiotropium Alone for Treatment of COPD , 2009, COPD.
[321] P. Jones,et al. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease , 2005, Thorax.
[322] C. Shim. Response to bronchodilators. , 1989, Clinics in chest medicine.
[323] D. Warburton,et al. Can increased understanding of the role of lung development and aging drive new advances in chronic obstructive pulmonary disease? , 2009, Proceedings of the American Thoracic Society.
[324] D. Sachs,et al. Individualizing medical treatment for tobacco dependence. , 1996, The European respiratory journal.
[325] J. Walters,et al. Barriers to the use of spirometry in general practice. , 2005, Australian family physician.
[326] David J Murphy,et al. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. , 2008, JAMA.
[327] P. Schnohr,et al. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study , 2006, Thorax.
[328] B. Make,et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[329] P. Jones,et al. The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.
[330] J. Bourbeau,et al. Inhaled tiotropium for stable chronic obstructive pulmonary disease. , 2000, The Cochrane database of systematic reviews.
[331] 张锺儒,et al. 对急性哮喘加剧的成年患者两种不同教育干预的评价[英]/Co^^té J…∥Am J Respir Crit Care Med , 2002 .
[332] J C Yernault,et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.
[333] Michael J. Allison,et al. COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study. , 2007, Chest.
[334] K. Murphy,et al. The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease. , 1991, The American review of respiratory disease.
[335] Katayoon Bahadori,et al. Risk factors of hospitalization and readmission of patients with COPD exacerbation – systematic review , 2007, International journal of chronic obstructive pulmonary disease.
[336] M. Decramer,et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial , 2005, The Lancet.
[337] D. Niewoehner,et al. Withdrawal of chronic systemic corticosteroids in patients with COPD: a randomized trial. , 2000, American journal of respiratory and critical care medicine.
[338] R. Casaburi,et al. Effect of hyperoxia on gas exchange and lactate kinetics following exercise onset in nonhypoxemic COPD patients. , 2002, Chest.
[339] Surinder S Birring,et al. Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study. , 2002, American journal of respiratory and critical care medicine.
[340] P. Anderson,et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial , 2001, The Lancet.
[341] D. Brooks,et al. Inspiratory Muscle Training Compared With Other Rehabilitation Interventions in Chronic Obstructive Pulmonary Disease: A SYSTEMATIC REVIEW UPDATE , 2008, Journal of cardiopulmonary rehabilitation and prevention.
[342] F. Speizer,et al. The relationship of nonspecific bronchial responsiveness to respiratory symptoms in a random population sample. , 1987, The American review of respiratory disease.
[343] J. V. van Noord,et al. A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group. , 2000, Thorax.
[344] R M Angus,et al. “Hospital at home” versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial , 2000, BMJ : British Medical Journal.
[345] D. Mannino,et al. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. , 2002, Morbidity and mortality weekly report. Surveillance summaries.
[346] J. Macmahon,et al. Cost minimisation analysis of provision of oxygen at home: are the Drug Tariff guidelines cost effective? , 1999, BMJ.
[347] I. Stiell,et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. , 2003, The New England journal of medicine.
[348] H. Rea,et al. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease , 2004, Internal medicine journal.
[349] J. Wilson,et al. Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD. , 1999, Chest.
[350] M. Aubier,et al. Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. , 1984, The New England journal of medicine.
[351] R. Rodríguez-Roisín,et al. Antibiotics for exacerbations of chronic obstructive pulmonary disease. , 2011, The Cochrane database of systematic reviews.
[352] M. Pathy,et al. Follow-up study of disability among elderly patients discharged from hospital with exacerbations of chronic bronchitis. , 1981, Thorax.
[353] A. Jones,et al. NO: COPD and beyond , 1997, Thorax.
[354] N J Wareham,et al. Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. , 2001, American journal of respiratory and critical care medicine.
[355] X. Busquets,et al. Systemic effects of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[356] S. Holgate,et al. The relationship between pneumonia in early childhood and impaired lung function in late adult life. , 1994, American journal of respiratory and critical care medicine.
[357] R. Dahl,et al. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[358] B. O'connor,et al. Superiority of “triple” therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD , 2008, Thorax.
[359] J. Wedzicha,et al. COPD exacerbations: definitions and classifications , 2003, European Respiratory Journal.
[360] M. Ardawi,et al. Effects of sheesha and cigarette smoking on pulmonary function of Saudi males and females. , 1988, Tropical and geographical medicine.
[361] Report of the Medical Research Council , 1936 .
[362] J. Costantino,et al. Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease. A randomized control study. , 1992, The American review of respiratory disease.
[363] I. Adcock,et al. Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy. , 2005, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[364] L. Trupin,et al. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease , 2005, Environmental health : a global access science source.
[365] R. Peto,et al. The natural history of chronic airflow obstruction. , 1977, British medical journal.
[366] W. Vollmer,et al. Marijuana and chronic obstructive lung disease: a population-based study , 2009, Canadian Medical Association Journal.
[367] J. Schouten,et al. Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences. , 1994, The European respiratory journal.
[368] P. Jones,et al. Oral theophylline for chronic obstructive pulmonary disease. , 2002, The Cochrane database of systematic reviews.
[369] W. Hop,et al. Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. , 2000, The European respiratory journal.
[370] D. Harrison,et al. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema , 1997, The Lancet.
[371] S. Woolf,et al. Report of the US Preventive Services Task Force. , 1990, JAMA.
[372] R. Pauwels,et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.
[373] E. Weitzenblum,et al. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. , 1985, The American review of respiratory disease.
[374] D. Johns,et al. Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease , 2005, Thorax.
[375] Andrew J. White,et al. Chronic obstructive pulmonary disease • 6: The aetiology of exacerbations of chronic obstructive pulmonary disease , 2003, Thorax.
[376] M. Ezzati. Indoor air pollution and health in developing countries , 2005, The Lancet.
[377] F. Rutten,et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. , 2005, European heart journal.
[378] T. Lasserson,et al. Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. , 2007, The Cochrane database of systematic reviews.
[379] J. McMurray,et al. Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial , 2009, European journal of heart failure.
[380] G. Marks,et al. Primary care Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease , 2022 .
[381] L. Stead,et al. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library , 2000, BMJ : British Medical Journal.
[382] M. Wittmann. [Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease]. , 1997, Pneumologie.
[383] Martyn R Partridge,et al. Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. , 2006, Chest.
[384] D. Taylor,et al. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. , 1985, The American review of respiratory disease.
[385] G. Guyatt,et al. Economic analysis of respiratory rehabilitation. , 1997, Chest.
[386] M. Elliott. Noninvasive ventilation in chronic ventilatory failure due to chronic obstructive pulmonary disease , 2002, European Respiratory Journal.
[387] R. Mellins,et al. Physician‐patient partnership in managing chronic illness , 1995, Academic medicine : journal of the Association of American Medical Colleges.
[388] S. Shepperd,et al. Randomised controlled trial comparing hospital at home care with inpatient hospital care. II: cost minimisation analysis. , 1998, BMJ.
[389] D. Mannino,et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.
[390] P. Jones,et al. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results , 2009, European Respiratory Journal.
[391] P. Schnohr,et al. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. , 1990, The American review of respiratory disease.
[392] Isabella Romagnoli,et al. Chest wall kinematics and breathlessness during pursed-lip breathing in patients with COPD. , 2004, Chest.
[393] Kirk R. Smith,et al. Maternal exposure to biomass smoke and reduced birth weight in Zimbabwe. , 2005, Annals of epidemiology.
[394] P. Laveneziana,et al. Dyspnea and Activity Limitation in COPD: Mechanical Factors , 2007, COPD.
[395] K. Rabe,et al. Complex chronic comorbidities of COPD , 2008, European Respiratory Journal.
[396] R. Stockley,et al. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. , 1999, American journal of respiratory and critical care medicine.
[397] P. Holt. Immune and inflammatory function in cigarette smokers. , 1987, Thorax.
[398] A. Esteban,et al. A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group. , 1995, The New England journal of medicine.
[399] A. Shroyer,et al. Updated evaluation of the cost-effectiveness of lung volume reduction surgery. , 2007, Chest.
[400] F. Martinez,et al. International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. , 2006 .
[401] P. Jones,et al. Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations , 2003, European Respiratory Journal.
[402] David G. Anderson,et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.
[403] M. Decramer,et al. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[404] T. Evald,et al. Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis. , 1994, Respiratory medicine.
[405] T. Petty,et al. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study. , 1989, The American review of respiratory disease.
[406] D. Mannino,et al. Global burden of COPD: systematic review and meta-analysis , 2006, European Respiratory Journal.
[407] D. Mannino,et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD , 2008, European Respiratory Journal.
[408] P. Metcalf,et al. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history , 2009, European Respiratory Journal.
[409] P. Hugh-Jones,et al. Long term changes in lung function after surgical treatment of bullous emphysema in smokers and ex-smokers. , 1984, Thorax.
[410] Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee. , 1985, Thorax.
[411] M. Decramer,et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial , 2009, The Lancet.
[412] A. Hansell,et al. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. , 2005, Chest.
[413] M. Aubier. Pharmacotherapy of respiratory muscles. , 1988, Clinics in chest medicine.
[414] N. Anthonisen,et al. Alteration in breathing pattern with progression of chronic obstructive pulmonary disease. , 2015, The American review of respiratory disease.
[415] M. Estenne,et al. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[416] Bridget Candy,et al. Effectiveness of innovations in nurse led chronic disease management for patients with chronic obstructive pulmonary disease: systematic review of evidence , 2005, BMJ : British Medical Journal.
[417] J. V. van Noord,et al. Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD , 2005, European Respiratory Journal.
[418] T. Egan. Reassessing the cost-effectiveness of lung transplantation. , 1996, Chest.
[419] D. Niewoehner,et al. Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction. , 1987, British journal of diseases of the chest.
[420] R. Sansores,et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[421] Sally J. Singh,et al. Randomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.
[422] G. Zeng,et al. Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease. , 2004, Chinese medical journal.
[423] F. Speizer,et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. , 1983, The American review of respiratory disease.
[424] S. Kalra,et al. INTERVAL VERSUS CONTINUOUS HIGH-INTENSITY EXERCISE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RANDOMIZED TRIAL , 2007 .
[425] P. Wagner,et al. Possible mechanisms underlying the development of cachexia in COPD , 2008, European Respiratory Journal.
[426] C. Jenkins,et al. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. , 2009, Chest.
[427] D. Górecka,et al. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. , 1997, Thorax.
[428] R. Rodríguez-Roisín,et al. Toward a consensus definition for COPD exacerbations. , 2000, Chest.
[429] I. Tager,et al. Maternal smoking during pregnancy. Effects on lung function during the first 18 months of life. , 1995, American journal of respiratory and critical care medicine.
[430] P. Plant,et al. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial , 2000, The Lancet.
[431] A. Buist,et al. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. , 1999, The American journal of medicine.
[433] M. Koopmanschap,et al. Cost-effectiveness of lung transplantation in The Netherlands: a scenario analysis. , 1998, Chest.
[434] B. Berg,et al. Oxygen supplementation during air travel in patients with chronic obstructive lung disease. , 1992, Chest.
[435] P. Vacek,et al. Evaluation of a community-based education program for individuals with chronic obstructive pulmonary disease. , 1980, Journal of rehabilitation.
[436] Bartolome Celli,et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.
[437] Alan D. Lopez,et al. The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020. , 1996 .
[438] P. Palange,et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. , 2004, Journal of applied physiology.
[439] P. Barnes. Bronchodilators: Basic Pharmacology , 1995 .
[440] K. Nichol,et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. , 1994, The New England journal of medicine.
[441] Onchee Yu,et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. , 2003, The New England journal of medicine.
[442] M J Connolly,et al. The effect of walking aids on exercise capacity and oxygenation in elderly patients with chronic obstructive pulmonary disease. , 1998, Age and ageing.
[443] E. Wouters,et al. Body composition and mortality in chronic obstructive pulmonary disease. , 2005, The American journal of clinical nutrition.
[444] B. Shah,et al. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. , 2006, The Indian journal of chest diseases & allied sciences.
[445] C. Bolliger,et al. Functional evaluation of the lung resection candidate. , 1998, The European respiratory journal.
[446] J. Steiner,et al. Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical findings alone? , 1993, The American journal of medicine.
[447] C. van Weel,et al. Consultation rates and incidence of intercurrent morbidity among patients with chronic disease in general practice. , 1994, The British journal of general practice : the journal of the Royal College of General Practitioners.
[448] S. Spencer,et al. Withdrawal from treatment as an outcome in the ISOLDE study of COPD. , 2003, Chest.
[449] R. Kaplan,et al. Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease: short-term effects on exercise endurance and health status. , 1990, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[450] A. Corrado,et al. The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients , 2002, European Respiratory Journal.
[451] D. Smith,et al. Five-year winter chemoprophylaxis for chronic bronchitis , 1969, British medical journal.
[452] M. Steiner,et al. Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial , 2003, Thorax.
[453] J. V. van Noord,et al. A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease , 2000 .
[454] B. Celli,et al. Exacerbations of chronic obstructive pulmonary disease , 2007, European Respiratory Journal.
[455] S. Yeh,et al. Reversal of COPD-associated weight loss using the anabolic agent oxandrolone. , 2002, Chest.
[456] D. Postma,et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease , 2005, Thorax.
[457] S. Solomon,et al. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT) , 2009, European journal of heart failure.
[458] N. Anthonisen,et al. Mortality in COPD: role of comorbidities , 2006, European Respiratory Journal.
[459] A. Ionescu,et al. What community measurements can be used to predict bone disease in patients with COPD? , 2008, Respiratory medicine.
[460] J. Wedzicha,et al. Management of acute exacerbation of chronic obstructive pulmonary disease , 2006 .
[461] A. Anzueto,et al. Noninvasive positive-pressure ventilation for respiratory failure after extubation. , 2004, The New England journal of medicine.
[462] J. Lawson. Comparative Quantification of Health Risks. Global and Regional Burden of Disease Attributable to Selected Major Risk Factors , 2006 .
[463] M. Niederman,et al. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. , 1998, Chest.
[464] M. Christ-Crain,et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial , 2004, The Lancet.
[465] B. Make,et al. Dyssynchronous breathing during arm but not leg exercise in patients with chronic airflow obstruction. , 1986, The New England journal of medicine.
[466] A. Diacon,et al. Functional evaluation before lung resection. , 2002, Clinics in chest medicine.
[467] H. C. Couch. Value of chemoprophylaxis and chemotherapy in early chronic bronchitis. A report to the Medical Research Council by their working party on trials of chemotherapy in early chronic bronchitis. , 1966, British medical journal.
[468] R. Pistelli,et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. , 1995, The American journal of medicine.
[469] S. Berk,et al. A case-control study on the effect of exposure to different substances on the development of COPD. , 2006, Annals of epidemiology.
[470] T. Seemungal,et al. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. , 2008, American journal of respiratory and critical care medicine.
[471] M. Antonelli,et al. Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial , 2002, Intensive Care Medicine.
[472] William C. Cockerham. Physicians , 2001, BMJ : British Medical Journal.
[473] Alan D. Lopez,et al. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.
[474] W. Dupont,et al. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. , 1994, The Journal of infectious diseases.
[475] P. Calverley,et al. Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease , 2003, European Respiratory Journal.
[476] A. Ionescu,et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.
[477] S. Anker,et al. Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. , 2006, International journal of cardiology.
[478] I. Rahman. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease , 2007, Cell Biochemistry and Biophysics.
[479] Ki Moon Bang,et al. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. , 2002, American journal of epidemiology.
[480] N. Anthonisen,et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial , 2005 .
[481] M. Raw,et al. Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Health Educational Authority. , 1998, Thorax.
[482] J. Bourbeau,et al. Tiotropium in Combination with Placebo, Salmeterol, or FluticasoneSalmeterol for Treatment of Chronic Obstructive Pulmonary Disease , 2007, Annals of Internal Medicine.
[483] P. Young,et al. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study , 2002, European Respiratory Journal.
[484] G. Guyatt,et al. A controlled trial of ambroxol in chronic bronchitis. , 1987, Chest.
[485] Deepti Malhotra,et al. Decline in Nrf2-regulated Antioxidants in Chronic Obstructive Pulmonary Disease Lungs Due to Loss of Its Positive Regulator, Dj-1 , 2022 .
[486] R. Phillips,et al. A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. , 1998, The American journal of medicine.
[487] H. Gunen,et al. The role of nebulised budesonide in the treatment of exacerbations of COPD , 2007, European Respiratory Journal.
[488] B. Fleury,et al. The cost of treating COPD patients with long-term oxygen therapy in a French population. , 1996, Chest.
[489] P. Moayyedi,et al. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease. , 1995, Thorax.
[490] A. Gulsvik,et al. Post-bronchodilator spirometry reference values in adults and implications for disease management. , 2006, American journal of respiratory and critical care medicine.
[491] D. O’Donnell,et al. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. , 1997, American journal of respiratory and critical care medicine.
[492] Alexander Rokitansky,et al. Thorax , 2009, Pediatric Surgery Digest.
[493] D. Georgopoulos. Symptoms and signs of COPD , 1991 .
[494] A. Buist,et al. Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. , 2000, Chest.
[495] D Olivieri,et al. Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomized, multicentre study (BREATH Trial). , 2002, Respiratory medicine.
[496] M. Svartengren,et al. Repeatability of airway deposition and tracheobronchial clearance rate over three days in chronic bronchitis. , 1995, The European respiratory journal.
[497] K. N. Maranetra,et al. Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients. , 2003, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[498] December,et al. International Consensus Conferences in Intensive Care Medicine: noninvasive positive pressure ventilation in acute Respiratory failure. , 2001 .
[499] D. O’Donnell,et al. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[500] M. Aubier,et al. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. , 1989, The New England journal of medicine.
[501] J. Wlodarczyk,et al. Severe exacerbation of chronic obstructive airways disease: health resource use in general practice and hospital. , 1998, Journal of quality in clinical practice.
[502] V. Peinado,et al. Pulmonary vascular involvement in COPD. , 2008, Chest.
[503] Martin J Connolly,et al. Early mobilization with walking aids following hospital admission with acute exacerbation of chronic obstructive pulmonary disease , 2003, Clinical rehabilitation.
[504] John P Griffin,et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). , 2007, Chest.
[505] J. Nicolás,et al. Non-invasive ventilation after extubation in hypercapnic patients with chronic respiratory disorders: randomised controlled trial , 2009, The Lancet.
[506] J. P. Davis,et al. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[507] A. Tattersfield,et al. Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. , 1991, The European respiratory journal.
[508] H. Folgering,et al. Pulmonary rehabilitation in chronic obstructive pulmonary disease. , 1998, The European respiratory journal.
[509] Stefano Guerra,et al. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study , 2007, The Lancet.
[510] B. Grant,et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. , 2002, The New England journal of medicine.
[511] J. Barberà,et al. Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. , 2009, Journal of applied physiology.
[512] R. Zuwallack,et al. An evaluation of nebulized levalbuterol in stable COPD. , 2003, Chest.
[513] A. Woodcock,et al. Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. , 1981, The New England journal of medicine.
[514] D. Jarvis,et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. , 2007, American journal of respiratory and critical care medicine.
[515] H. Folgering,et al. Target-flow inspiratory muscle training during pulmonary rehabilitation in patients with COPD. , 1991, Chest.
[516] P. Macklem,et al. Nutritional status and mortality in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[517] S. V. van Eeden,et al. Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease , 2009, International journal of chronic obstructive pulmonary disease.
[518] H. Magnussen,et al. Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease. , 2000, Respiratory medicine.
[519] E. Salpeter,et al. Cardioselective beta-blockers for chronic obstructive pulmonary disease. , 2005, The Cochrane database of systematic reviews.
[520] E. Salpeter,et al. Cardioselective beta-blockers for chronic obstructive pulmonary disease. , 2005, The Cochrane database of systematic reviews.
[521] J. Muñoz,et al. Clinical efficacy of anti-pneumococcal vaccination in patients with COPD , 2005, Thorax.
[522] W. Holland,et al. Influence of passive smoking and parental phlegm on pneumonia and bronchitis in early childhood. , 1974, Lancet.
[523] S. Guerra,et al. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk , 2009, Thorax.
[524] R. Kaplan,et al. Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. , 2003, American journal of respiratory and critical care medicine.
[525] J. Crowley,et al. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. , 1996, American journal of respiratory and critical care medicine.
[526] P. Macklem,et al. Effect of negative pressure ventilation in severe chronic obstructive pulmonary disease , 1992, The Lancet.
[527] M. Nishimura,et al. COPD in Japan: the Nippon COPD Epidemiology study , 2004, Respirology.
[528] T. Seemungal,et al. Chlamydia pneumoniae and COPD exacerbation , 2002, Thorax.
[529] B. O'driscoll,et al. A long-term prospective assessment of home nebulizer treatment. , 1992, Respiratory medicine.
[530] Phillips Yy,et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.
[531] M. Shulman,et al. Preoperative pulmonary evaluation. , 1999 .
[532] J. Collet,et al. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. , 1997, American journal of respiratory and critical care medicine.
[533] C. Vogelmeier,et al. Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study. , 2008, Respiratory medicine.
[534] D. Postma,et al. Severe chronic airflow obstruction: can corticosteroids slow down progression? , 1985, European journal of respiratory diseases.
[535] N. Pride,et al. Flow-volume curves and sleep-disordered breathing , 1983, Thorax.
[536] J. Stoller,et al. Inpatient management of chronic obstructive pulmonary disease. , 1998, Respiratory care clinics of North America.
[537] G. Guyatt,et al. A measure of quality of life for clinical trials in chronic lung disease. , 1987, Thorax.
[538] T. Seemungal,et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[539] G. Bonsel,et al. Technology Assessment of the Dutch Lung Transplantation Program , 1998, International Journal of Technology Assessment in Health Care.
[540] T. Seemungal,et al. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. , 2008, American journal of respiratory and critical care medicine.
[541] R. Anziano,et al. Long-term fatty fish consumption and renal cell carcinoma incidence in women. , 2006, JAMA.
[542] R. Rodríguez-Roisín,et al. COPD exacerbations · 5: Management , 2006, Thorax.
[543] J. Vestbo,et al. COPD stage and risk of hospitalization for infectious disease. , 2008, Chest.
[544] J. Hankinson,et al. Interpretative strategies for lung function tests , 2005, European Respiratory Journal.
[545] J. Wedzicha,et al. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease , 1993, The Lancet.
[546] C. C. Christensen,et al. Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438 m (8,000 ft) altitude. , 2000, The European respiratory journal.
[547] B. Forsberg,et al. Shedding new light on wood smoke: a risk factor for respiratory health , 2006, European Respiratory Journal.
[548] A. Connors,et al. Relationship between arterial blood gases and spirometry in acute exacerbations of chronic obstructive pulmonary disease. , 1989, Annals of emergency medicine.
[549] Stefano Guerra,et al. Asthma as a risk factor for COPD in a longitudinal study. , 2004, Chest.
[550] A. Ghio,et al. Ambient air pollution particles and the acute exacerbation of chronic obstructive pulmonary disease. , 2008, Inhalation toxicology.
[551] P. Jones,et al. Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. , 1998, The European respiratory journal.
[552] J. van der Palen,et al. Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. , 2002, American journal of respiratory and critical care medicine.
[553] V M Hawthorne,et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study , 1996, BMJ.
[554] N. Anthonisen. OM-8BV for COPD. , 1997, American journal of respiratory and critical care medicine.
[555] S. Spencer,et al. Impact of preventing exacerbations on deterioration of health status in COPD , 2004, European Respiratory Journal.
[556] R. W. Hawkins,et al. Upper extremity exercise training in chronic obstructive pulmonary disease. , 1988, Chest.
[557] E. Silverman,et al. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[558] F. Martinez,et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. , 2006, The Annals of thoracic surgery.
[559] A. Woodcock,et al. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. , 1992, The European respiratory journal.
[560] E. Wouters. The burden of COPD in The Netherlands: results from the Confronting COPD survey. , 2003, Respiratory medicine.
[561] Neuropsychological deficits in chronic obstructive pulmonary disease. , 1996, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[562] T. Todisco,et al. Mild prematurity and respiratory functions , 2005, European Journal of Pediatrics.
[563] S. Antoniu,et al. Hospitalizations and mortality in the Lung Health Study , 2002, Expert review of pharmacoeconomics & outcomes research.
[564] R N Battista,et al. Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. , 1988, JAMA.
[565] R. Zuwallack,et al. Pulmonary rehabilitation - 1999 , 1999 .
[566] B. Lipworth,et al. Hypokalemic and ECG sequelae of combined beta-agonist/diuretic therapy. Protection by conventional doses of spironolactone but not triamterene. , 1990, Chest.
[567] L. Brochard,et al. Comparison of three methods of gradual withdrawal from ventilatory support during weaning from mechanical ventilation. , 1994, American journal of respiratory and critical care medicine.
[568] A. Sharafkhaneh,et al. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial , 2007, Psychological Medicine.
[569] M. Teghtsoonian,et al. Distinguishable types of dyspnea in patients with shortness of breath. , 1990, The American review of respiratory disease.
[570] P. Jones,et al. Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.
[571] A. Churg,et al. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment , 2005, Thorax.
[572] D. Harrison,et al. Implications of prognostic pessimism in patients with chronic obstructive pulmonary disease (COPD) or asthma admitted to intensive care in the UK within the COPD and asthma outcome study (CAOS): multicentre observational cohort study , 2007, BMJ : British Medical Journal.
[573] J. Montserrat,et al. Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease. , 1988, The European respiratory journal.
[574] S. Aaron,et al. Physiological changes during symptom recovery from moderate exacerbations of COPD , 2005, European Respiratory Journal.
[575] H. D. Short,et al. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. , 1987, The American review of respiratory disease.
[576] J. Connett,et al. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.
[577] L. Goldman,et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) , 2009, European Respiratory Journal.
[578] Salvador Benito,et al. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. , 2002, JAMA.
[579] S. Yancey,et al. Efficacy of salmeterol xinafoate in the treatment of COPD. , 1999, Chest.
[580] J. Barberà,et al. Effect of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.
[581] S. Borson,et al. Anxiety and depression in COPD: Current understanding, unanswered questions, and research needs. , 2009, Revista portuguesa de pneumologia.
[582] E. Wouters,et al. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. , 1994, The European respiratory journal.
[583] A. Thomson,et al. Value of theophylline treatment in patients handicapped by chronic obstructive lung disease. , 1993, Thorax.
[584] D. O’Donnell,et al. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[585] W. Knaus,et al. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. , 1996, JAMA.
[586] H. Warwick,et al. Smoke - the Killer in the Kitchen: Indoor Air Pollution in Developing Countries , 2004 .
[587] A. Buist,et al. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers , 2002, European Respiratory Journal.
[588] F. Speizer,et al. The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms. , 1988, The American review of respiratory disease.
[589] E. Pehlivan,et al. Factors affecting survival of hospitalised patients with COPD , 2005, European Respiratory Journal.
[590] H. Folgering,et al. Nocturnal saturation improves by target-flow inspiratory muscle training in patients with COPD. , 1996, American journal of respiratory and critical care medicine.
[591] A. Kelly,et al. How accurate are pulse oximeters in patients with acute exacerbations of chronic obstructive airways disease? , 2001, Respiratory medicine.
[592] Scott T. Weiss,et al. A Genome-Wide Association Study of Pulmonary Function Measures in the Framingham Heart Study , 2009, PLoS genetics.
[593] I. Weisman. Cardiopulmonary exercise testing in the preoperative assessment for lung resection surgery. , 2001, Seminars in thoracic and cardiovascular surgery.
[594] D. Niewoehner,et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. , 1999, The New England journal of medicine.
[595] R. Stockley. Neutrophils and the pathogenesis of COPD. , 2002, Chest.
[596] F. Blasi,et al. Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment , 2002, Thorax.
[597] T. Welte,et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. , 2009, American journal of respiratory and critical care medicine.
[598] R. Pauwels,et al. Spirometry in primary care: is it good enough to face demands like World COPD Day? , 2003, European Respiratory Journal.
[599] M. Estenne,et al. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. , 1998, Heart & lung : the journal of critical care.
[600] G. Kwakkel,et al. Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis , 2002, European Respiratory Journal.
[601] M. H. Williams,et al. Bronchodilator response to oral aminophylline and terbutaline versus aerosol albuterol in patients with chronic obstructive pulmonary disease. , 1983, The American journal of medicine.
[602] W. Hall,et al. Meta-analytic review of the efficacy of smoking cessation interventions. , 1994, Drug and alcohol review.
[603] P. Schlattmann,et al. A randomised, controlled study on the effects of a short-term endurance training programme in patients with major depression , 2006, British Journal of Sports Medicine.
[604] O. Johnell,et al. Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler® , 2002, European Respiratory Journal.
[605] N. Gross,et al. Effects of salmeterol on arterial blood gases in patients with stable chronic obstructive pulmonary disease. Comparison with albuterol and ipratropium. , 1999, American journal of respiratory and critical care medicine.
[606] J. Larson. The MOS 36-Item Short form Health Survey , 1997, Evaluation & the health professions.
[607] R. Pauwels,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.
[608] Edwin K Silverman,et al. Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. , 2002, American journal of human genetics.
[609] J. Barberà,et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. , 1997, The European respiratory journal.
[610] D. Postma,et al. Effects of long-term treatment with corticosteroids in COPD. , 1996, Chest.
[611] Thomas Similowski,et al. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. , 2005, Chest.
[612] E. Salpeter,et al. Cardioselective beta-blockers for chronic obstructive pulmonary disease. , 2005, The Cochrane database of systematic reviews.
[613] L. Fabbri,et al. Cellular and structural bases of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[614] G. Filippatos,et al. Guidelines for the diagnosis and treatment of pulmonary hypertension , 2009 .
[615] G. Della Cioppa,et al. Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD. , 2002, Chest.
[616] A. Buist,et al. Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group. , 1997, Chest.
[617] J. Ruiz,et al. Risk factors for lower airway bacterial colonization in chronic bronchitis. , 1999, The European respiratory journal.
[618] Dirkje S Postma,et al. Health and Quality of Life Outcomes , 2003 .
[619] D. Postma,et al. Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction? , 1988, The European respiratory journal.
[620] D. Postma,et al. Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study. , 2007, Chest.
[621] P. Tousignant,et al. The health and cost effects of substituting home care for inpatient acute care: a review of the evidence. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[622] J. Steurer,et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. , 2009, The Cochrane database of systematic reviews.
[623] P. Laveneziana,et al. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD , 2008, Thorax.
[624] M. Polkey,et al. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study , 2004, BMJ : British Medical Journal.
[625] M. Koopmanschap,et al. Lifetime costs of lung transplantation: estimation of incremental costs. , 1997, Health economics.
[626] Alvar Agusti,et al. Immunologic aspects of chronic obstructive pulmonary disease. , 2009, The New England journal of medicine.
[627] R. Dittus,et al. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. , 1991, Annals of internal medicine.
[628] R. Hubbard,et al. Detecting chronic obstructive pulmonary disease using peak flow rate: cross sectional survey , 2003, BMJ : British Medical Journal.